# Anticancer Activity of Nicotinamide on Lung Cancer

> **NCT02416739** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Il Yeong Park, Ph.D.** · enrollment: 110 (actual)

## Conditions studied

- Non-Small-Cell Lung Carcinoma

## Interventions

- **DRUG:** Nicotinamide

## Key facts

- **NCT ID:** NCT02416739
- **Lead sponsor:** Il Yeong Park, Ph.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03
- **Primary completion:** 2020-03
- **Final completion:** 2020-06
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2020-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02416739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02416739, "Anticancer Activity of Nicotinamide on Lung Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02416739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*